rs144225009

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6BP7BS2

The NM_021120.4(DLG3):​c.429C>T​(p.Phe143Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00177 in 1,209,847 control chromosomes in the GnomAD database, including 2 homozygotes. There are 653 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., 38 hem., cov: 22)
Exomes 𝑓: 0.0018 ( 2 hom. 615 hem. )

Consequence

DLG3
NM_021120.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 2.53

Publications

1 publications found
Variant links:
Genes affected
DLG3 (HGNC:2902): (discs large MAGUK scaffold protein 3) This gene encodes a member of the membrane-associated guanylate kinase protein family. The encoded protein may play a role in clustering of NMDA receptors at excitatory synapses. It may also negatively regulate cell proliferation through interaction with the C-terminal region of the adenomatosis polyposis coli tumor suppressor protein. Mutations in this gene have been associated with X-linked cognitive disability. Alternatively spliced transcript variants have been described. [provided by RefSeq, Oct 2009]
DLG3 Gene-Disease associations (from GenCC):
  • intellectual disability, X-linked 90
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant X-70449379-C-T is Benign according to our data. Variant chrX-70449379-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210852.
BP7
Synonymous conserved (PhyloP=2.53 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 38 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DLG3NM_021120.4 linkc.429C>T p.Phe143Phe synonymous_variant Exon 3 of 19 ENST00000374360.8 NP_066943.2 Q92796-1Q59FY1
DLG3XM_006724625.3 linkc.429C>T p.Phe143Phe synonymous_variant Exon 3 of 20 XP_006724688.1
DLG3XM_011530883.2 linkc.429C>T p.Phe143Phe synonymous_variant Exon 3 of 19 XP_011529185.1
DLG3XM_006724626.3 linkc.429C>T p.Phe143Phe synonymous_variant Exon 3 of 20 XP_006724689.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DLG3ENST00000374360.8 linkc.429C>T p.Phe143Phe synonymous_variant Exon 3 of 19 1 NM_021120.4 ENSP00000363480.3 Q92796-1
DLG3ENST00000194900.8 linkc.483C>T p.Phe161Phe synonymous_variant Exon 4 of 21 5 ENSP00000194900.4 Q5JUW8
DLG3ENST00000463252.5 linkn.495C>T non_coding_transcript_exon_variant Exon 3 of 19 5

Frequencies

GnomAD3 genomes
AF:
0.00123
AC:
137
AN:
111598
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000261
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000378
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00133
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00216
Gnomad OTH
AF:
0.00133
GnomAD2 exomes
AF:
0.00134
AC:
246
AN:
183102
AF XY:
0.00133
show subpopulations
Gnomad AFR exome
AF:
0.000152
Gnomad AMR exome
AF:
0.000583
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00138
Gnomad NFE exome
AF:
0.00240
Gnomad OTH exome
AF:
0.00199
GnomAD4 exome
AF:
0.00182
AC:
2002
AN:
1098195
Hom.:
2
Cov.:
32
AF XY:
0.00169
AC XY:
615
AN XY:
363555
show subpopulations
African (AFR)
AF:
0.000114
AC:
3
AN:
26402
American (AMR)
AF:
0.000454
AC:
16
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19385
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.0000369
AC:
2
AN:
54148
European-Finnish (FIN)
AF:
0.00188
AC:
76
AN:
40528
Middle Eastern (MID)
AF:
0.00411
AC:
17
AN:
4137
European-Non Finnish (NFE)
AF:
0.00216
AC:
1818
AN:
842085
Other (OTH)
AF:
0.00152
AC:
70
AN:
46097
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
83
167
250
334
417
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00123
AC:
137
AN:
111652
Hom.:
0
Cov.:
22
AF XY:
0.00112
AC XY:
38
AN XY:
33806
show subpopulations
African (AFR)
AF:
0.000261
AC:
8
AN:
30694
American (AMR)
AF:
0.000378
AC:
4
AN:
10583
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3547
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2598
European-Finnish (FIN)
AF:
0.00133
AC:
8
AN:
6037
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.00216
AC:
115
AN:
53123
Other (OTH)
AF:
0.00131
AC:
2
AN:
1522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00108
Hom.:
13
Bravo
AF:
0.000910
EpiCase
AF:
0.00207
EpiControl
AF:
0.00196

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Nov 09, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 18, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
13
DANN
Benign
0.84
PhyloP100
2.5
Mutation Taster
=83/17
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144225009; hg19: chrX-69669229; API